Global Meloxicam Drug Market Research Report 2020


This report focuses on Meloxicam Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Meloxicam Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    Boehringer-Ingelheim
    TerSera Therapeutics
    Iroko Pharmaceuticals
    Apotex
    Yung Shin Pharmaceutical
    Breckenridge Pharmaceutical
    Zydus Pharmaceuticals
    Unichem Pharmaceuticals
    Strides Pharma
    Cipla
    Dr. Reddy's Laboratories
    Glenmark Pharmaceuticals
    Teva
    PuraCap Pharmaceutical
    TARO
    Lupin Pharmaceuticals
    Aurobindo Pharma

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Tablet
    Capsule

Segment by Application
    Osteoarthritis in adults (OA)
    Rheumatoid Arthritis in adults (RA)
    Pediatric patients
Table of Contents

1 Meloxicam Drug Market Overview
    1.1 Product Overview and Scope of Meloxicam Drug
    1.2 Meloxicam Drug Segment by Type
        1.2.1 Global Meloxicam Drug Sales Growth Rate Comparison by Type (2021-2026)
        1.2.2 Tablet
        1.2.3 Capsule
    1.3 Meloxicam Drug Segment by Application
        1.3.1 Meloxicam Drug Sales Comparison by Application: 2020 VS 2026
        1.3.2 Osteoarthritis in adults (OA)
        1.3.3 Rheumatoid Arthritis in adults (RA)
        1.3.4 Pediatric patients
    1.4 Global Meloxicam Drug Market Size Estimates and Forecasts
        1.4.1 Global Meloxicam Drug Revenue 2015-2026
        1.4.2 Global Meloxicam Drug Sales 2015-2026
        1.4.3 Meloxicam Drug Market Size by Region: 2020 Versus 2026

2 Global Meloxicam Drug Market Competition by Manufacturers
    2.1 Global Meloxicam Drug Sales Market Share by Manufacturers (2015-2020)
    2.2 Global Meloxicam Drug Revenue Share by Manufacturers (2015-2020)
    2.3 Global Meloxicam Drug Average Price by Manufacturers (2015-2020)
    2.4 Manufacturers Meloxicam Drug Manufacturing Sites, Area Served, Product Type
    2.5 Meloxicam Drug Market Competitive Situation and Trends
        2.5.1 Meloxicam Drug Market Concentration Rate
        2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
        2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    2.7 Primary Interviews with Key Meloxicam Drug Players (Opinion Leaders)

3 Meloxicam Drug Retrospective Market Scenario by Region
    3.1 Global Meloxicam Drug Retrospective Market Scenario in Sales by Region: 2015-2020
    3.2 Global Meloxicam Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
    3.3 North America Meloxicam Drug Market Facts & Figures by Country
        3.3.1 North America Meloxicam Drug Sales by Country
        3.3.2 North America Meloxicam Drug Sales by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Meloxicam Drug Market Facts & Figures by Country
        3.4.1 Europe Meloxicam Drug Sales by Country
        3.4.2 Europe Meloxicam Drug Sales by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Meloxicam Drug Market Facts & Figures by Region
        3.5.1 Asia Pacific Meloxicam Drug Sales by Region
        3.5.2 Asia Pacific Meloxicam Drug Sales by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Meloxicam Drug Market Facts & Figures by Country
        3.6.1 Latin America Meloxicam Drug Sales by Country
        3.6.2 Latin America Meloxicam Drug Sales by Country
        3.6.3 Mexico
        3.6.3 Brazil
        3.6.3 Argentina
    3.7 Middle East and Africa Meloxicam Drug Market Facts & Figures by Country
        3.7.1 Middle East and Africa Meloxicam Drug Sales by Country
        3.7.2 Middle East and Africa Meloxicam Drug Sales by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global Meloxicam Drug Historic Market Analysis by Type
    4.1 Global Meloxicam Drug Sales Market Share by Type (2015-2020)
    4.2 Global Meloxicam Drug Revenue Market Share by Type (2015-2020)
    4.3 Global Meloxicam Drug Price Market Share by Type (2015-2020)
    4.4 Global Meloxicam Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Meloxicam Drug Historic Market Analysis by Application
    5.1 Global Meloxicam Drug Sales Market Share by Application (2015-2020)
    5.2 Global Meloxicam Drug Revenue Market Share by Application (2015-2020)
    5.3 Global Meloxicam Drug Price by Application (2015-2020)

6 Company Profiles and Key Figures in Meloxicam Drug Business
    6.1 Boehringer-Ingelheim
        6.1.1 Corporation Information
        6.1.2 Boehringer-Ingelheim Description, Business Overview and Total Revenue
        6.1.3 Boehringer-Ingelheim Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
        6.1.4 Boehringer-Ingelheim Products Offered
        6.1.5 Boehringer-Ingelheim Recent Development
    6.2 TerSera Therapeutics
        6.2.1 TerSera Therapeutics Meloxicam Drug Production Sites and Area Served
        6.2.2 TerSera Therapeutics Description, Business Overview and Total Revenue
        6.2.3 TerSera Therapeutics Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
        6.2.4 TerSera Therapeutics Products Offered
        6.2.5 TerSera Therapeutics Recent Development
    6.3 Iroko Pharmaceuticals
        6.3.1 Iroko Pharmaceuticals Meloxicam Drug Production Sites and Area Served
        6.3.2 Iroko Pharmaceuticals Description, Business Overview and Total Revenue
        6.3.3 Iroko Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
        6.3.4 Iroko Pharmaceuticals Products Offered
        6.3.5 Iroko Pharmaceuticals Recent Development
    6.4 Apotex
        6.4.1 Apotex Meloxicam Drug Production Sites and Area Served
        6.4.2 Apotex Description, Business Overview and Total Revenue
        6.4.3 Apotex Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
        6.4.4 Apotex Products Offered
        6.4.5 Apotex Recent Development
    6.5 Yung Shin Pharmaceutical
        6.5.1 Yung Shin Pharmaceutical Meloxicam Drug Production Sites and Area Served
        6.5.2 Yung Shin Pharmaceutical Description, Business Overview and Total Revenue
        6.5.3 Yung Shin Pharmaceutical Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
        6.5.4 Yung Shin Pharmaceutical Products Offered
        6.5.5 Yung Shin Pharmaceutical Recent Development
    6.6 Breckenridge Pharmaceutical
        6.6.1 Breckenridge Pharmaceutical Meloxicam Drug Production Sites and Area Served
        6.6.2 Breckenridge Pharmaceutical Description, Business Overview and Total Revenue
        6.6.3 Breckenridge Pharmaceutical Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
        6.6.4 Breckenridge Pharmaceutical Products Offered
        6.6.5 Breckenridge Pharmaceutical Recent Development
    6.7 Zydus Pharmaceuticals
        6.6.1 Zydus Pharmaceuticals Meloxicam Drug Production Sites and Area Served
        6.6.2 Zydus Pharmaceuticals Description, Business Overview and Total Revenue
        6.6.3 Zydus Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
        6.4.4 Zydus Pharmaceuticals Products Offered
        6.7.5 Zydus Pharmaceuticals Recent Development
    6.8 Unichem Pharmaceuticals
        6.8.1 Unichem Pharmaceuticals Meloxicam Drug Production Sites and Area Served
        6.8.2 Unichem Pharmaceuticals Description, Business Overview and Total Revenue
        6.8.3 Unichem Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
        6.8.4 Unichem Pharmaceuticals Products Offered
        6.8.5 Unichem Pharmaceuticals Recent Development
    6.9 Strides Pharma
        6.9.1 Strides Pharma Meloxicam Drug Production Sites and Area Served
        6.9.2 Strides Pharma Description, Business Overview and Total Revenue
        6.9.3 Strides Pharma Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
        6.9.4 Strides Pharma Products Offered
        6.9.5 Strides Pharma Recent Development
    6.10 Cipla
        6.10.1 Cipla Meloxicam Drug Production Sites and Area Served
        6.10.2 Cipla Description, Business Overview and Total Revenue
        6.10.3 Cipla Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
        6.10.4 Cipla Products Offered
        6.10.5 Cipla Recent Development
    6.11 Dr. Reddy's Laboratories
        6.11.1 Dr. Reddy's Laboratories Meloxicam Drug Production Sites and Area Served
        6.11.2 Dr. Reddy's Laboratories Meloxicam Drug Description, Business Overview and Total Revenue
        6.11.3 Dr. Reddy's Laboratories Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
        6.11.4 Dr. Reddy's Laboratories Products Offered
        6.11.5 Dr. Reddy's Laboratories Recent Development
    6.12 Glenmark Pharmaceuticals
        6.12.1 Glenmark Pharmaceuticals Meloxicam Drug Production Sites and Area Served
        6.12.2 Glenmark Pharmaceuticals Meloxicam Drug Description, Business Overview and Total Revenue
        6.12.3 Glenmark Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
        6.12.4 Glenmark Pharmaceuticals Products Offered
        6.12.5 Glenmark Pharmaceuticals Recent Development
    6.13 Teva
        6.13.1 Teva Meloxicam Drug Production Sites and Area Served
        6.13.2 Teva Meloxicam Drug Description, Business Overview and Total Revenue
        6.13.3 Teva Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
        6.13.4 Teva Products Offered
        6.13.5 Teva Recent Development
    6.14 PuraCap Pharmaceutical
        6.14.1 PuraCap Pharmaceutical Meloxicam Drug Production Sites and Area Served
        6.14.2 PuraCap Pharmaceutical Meloxicam Drug Description, Business Overview and Total Revenue
        6.14.3 PuraCap Pharmaceutical Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
        6.14.4 PuraCap Pharmaceutical Products Offered
        6.14.5 PuraCap Pharmaceutical Recent Development
    6.15 TARO
        6.15.1 TARO Meloxicam Drug Production Sites and Area Served
        6.15.2 TARO Meloxicam Drug Description, Business Overview and Total Revenue
        6.15.3 TARO Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
        6.15.4 TARO Products Offered
        6.15.5 TARO Recent Development
    6.16 Lupin Pharmaceuticals
        6.16.1 Lupin Pharmaceuticals Meloxicam Drug Production Sites and Area Served
        6.16.2 Lupin Pharmaceuticals Meloxicam Drug Description, Business Overview and Total Revenue
        6.16.3 Lupin Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
        6.16.4 Lupin Pharmaceuticals Products Offered
        6.16.5 Lupin Pharmaceuticals Recent Development
    6.17 Aurobindo Pharma
        6.17.1 Aurobindo Pharma Meloxicam Drug Production Sites and Area Served
        6.17.2 Aurobindo Pharma Meloxicam Drug Description, Business Overview and Total Revenue
        6.17.3 Aurobindo Pharma Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
        6.17.4 Aurobindo Pharma Products Offered
        6.17.5 Aurobindo Pharma Recent Development

7 Meloxicam Drug Manufacturing Cost Analysis
    7.1 Meloxicam Drug Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Raw Materials Price Trend
       7.1.3 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Meloxicam Drug
    7.4 Meloxicam Drug Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Meloxicam Drug Distributors List
    8.3 Meloxicam Drug Customers

9 Market Dynamics
    9.1 Market Trends
    9.2 Opportunities and Drivers
    9.3 Challenges
    9.4 Porter's Five Forces Analysis

10 Global Market Forecast
    10.1 Global Meloxicam Drug Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Meloxicam Drug by Type (2021-2026)
        10.1.2 Global Forecasted Revenue of Meloxicam Drug by Type (2021-2026)
    10.2 Meloxicam Drug Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Meloxicam Drug by Application (2021-2026)
        10.2.2 Global Forecasted Revenue of Meloxicam Drug by Application (2021-2026)
    10.3 Meloxicam Drug Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Meloxicam Drug by Region (2021-2026)
        10.3.2 Global Forecasted Revenue of Meloxicam Drug by Region (2021-2026)
    10.4 North America Meloxicam Drug Estimates and Projections (2021-2026)
    10.5 Europe Meloxicam Drug Estimates and Projections (2021-2026)
    10.6 Asia Pacific Meloxicam Drug Estimates and Projections (2021-2026)
    10.7 Latin America Meloxicam Drug Estimates and Projections (2021-2026)
    10.8 Middle East and Africa Meloxicam Drug Estimates and Projections (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables Table 1. Global Meloxicam Drug Sales (K MT) Growth Rate Comparison by Type (2015-2026) Table 2. Global Meloxicam Drug Sales (K MT) Comparison by Application: 2020 VS 2026 Table 3. Global Meloxicam Drug Market Size by Type (K MT) (US$ Million) (2020 VS 2026) Table 4. Global Key Meloxicam Drug Manufacturers Covered in This Study Table 5. Global Meloxicam Drug Sales (K MT) by Manufacturers (2015-2020) Table 6. Global Meloxicam Drug Sales Share by Manufacturers (2015-2020) Table 7. Global Meloxicam Drug Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Meloxicam Drug Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Meloxicam Drug Average Price (USD/MT) of Key Manufacturers (2015-2020) Table 10. Manufacturers Meloxicam Drug Sales Sites and Area Served Table 11. Manufacturers Meloxicam Drug Product Types Table 12. Global Meloxicam Drug Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Meloxicam Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meloxicam Drug as of 2019) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Meloxicam Drug Players Table 16. Global Meloxicam Drug Sales (K MT) by Region (2015-2020) Table 17. Global Meloxicam Drug Sales Market Share by Region (2015-2020) Table 18. Global Meloxicam Drug Revenue (Million US$) by Region (2015-2020) Table 19. Global Meloxicam Drug Revenue Market Share by Region (2015-2020) Table 20. North America Meloxicam Drug Sales by Country (2015-2020) (K MT) Table 21. North America Meloxicam Drug Sales Market Share by Country (2015-2020) Table 22. North America Meloxicam Drug Revenue by Country (2015-2020) (US$ Million) Table 23. North America Meloxicam Drug Revenue Market Share by Country (2015-2020) Table 24. Europe Meloxicam Drug Sales by Country (2015-2020) (K MT) Table 25. Europe Meloxicam Drug Sales Market Share by Country (2015-2020) Table 26. Europe Meloxicam Drug Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Meloxicam Drug Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Meloxicam Drug Sales by Region (2015-2020) (K MT) Table 29. Asia Pacific Meloxicam Drug Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Meloxicam Drug Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Meloxicam Drug Revenue Market Share by Region (2015-2020) Table 32. Latin America Meloxicam Drug Sales by Country (2015-2020) (K MT) Table 33. Latin America Meloxicam Drug Sales Market Share by Country (2015-2020) Table 34. Latin America Meloxicam Drug Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Meloxicam Drug Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Meloxicam Drug Sales by Country (2015-2020) (K MT) Table 37. Middle East and Africa Meloxicam Drug Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Meloxicam Drug Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Meloxicam Drug Revenue Market Share by Country (2015-2020) Table 40. Global Meloxicam Drug Sales (K MT) by Type (2015-2020) Table 41. Global Meloxicam Drug Sales Share by Type (2015-2020) Table 42. Global Meloxicam Drug Revenue (Million US$) by Type (2015-2020) Table 43. Global Meloxicam Drug Revenue Share by Type (2015-2020) Table 44. Global Meloxicam Drug Price (USD/MT) by Type (2015-2020) Table 45. Global Meloxicam Drug Sales (K MT) by Application (2015-2020) Table 46. Global Meloxicam Drug Sales Market Share by Application (2015-2020) Table 47. Global Meloxicam Drug Sales Growth Rate by Application (2015-2020) Table 48. Boehringer-Ingelheim Meloxicam Drug Corporation Information Table 49. Boehringer-Ingelheim Description and Business Overview Table 50. Boehringer-Ingelheim Meloxicam Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 51. Boehringer-Ingelheim Main Product Table 52. Boehringer-Ingelheim Recent Development Table 53. TerSera Therapeutics Meloxicam Drug Corporation Information Table 54. TerSera Therapeutics Corporation Information Table 55. TerSera Therapeutics Meloxicam Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 56. TerSera Therapeutics Main Product Table 57. TerSera Therapeutics Recent Development Table 58. Iroko Pharmaceuticals Meloxicam Drug Corporation Information Table 59. Iroko Pharmaceuticals Corporation Information Table 60. Iroko Pharmaceuticals Meloxicam Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 61. Iroko Pharmaceuticals Main Product Table 62. Iroko Pharmaceuticals Recent Development Table 63. Apotex Meloxicam Drug Corporation Information Table 64. Apotex Corporation Information Table 65. Apotex Meloxicam Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 66. Apotex Main Product Table 67. Apotex Recent Development Table 68. Yung Shin Pharmaceutical Meloxicam Drug Corporation Information Table 69. Yung Shin Pharmaceutical Corporation Information Table 70. Yung Shin Pharmaceutical Meloxicam Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 71. Yung Shin Pharmaceutical Main Product Table 72. Yung Shin Pharmaceutical Recent Development Table 73. Breckenridge Pharmaceutical Meloxicam Drug Corporation Information Table 74. Breckenridge Pharmaceutical Corporation Information Table 75. Breckenridge Pharmaceutical Meloxicam Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 76. Breckenridge Pharmaceutical Main Product Table 77. Breckenridge Pharmaceutical Recent Development Table 78. Zydus Pharmaceuticals Meloxicam Drug Corporation Information Table 79. Zydus Pharmaceuticals Corporation Information Table 80. Zydus Pharmaceuticals Meloxicam Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 81. Zydus Pharmaceuticals Main Product Table 82. Zydus Pharmaceuticals Recent Development Table 83. Unichem Pharmaceuticals Meloxicam Drug Corporation Information Table 84. Unichem Pharmaceuticals Corporation Information Table 85. Unichem Pharmaceuticals Meloxicam Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 86. Unichem Pharmaceuticals Main Product Table 87. Unichem Pharmaceuticals Recent Development Table 88. Strides Pharma Meloxicam Drug Corporation Information Table 89. Strides Pharma Corporation Information Table 90. Strides Pharma Meloxicam Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 91. Strides Pharma Main Product Table 92. Strides Pharma Recent Development Table 93. Cipla Meloxicam Drug Corporation Information Table 94. Cipla Corporation Information Table 95. Cipla Meloxicam Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 96. Cipla Main Product Table 97. Cipla Recent Development Table 98. Dr. Reddy's Laboratories Meloxicam Drug Corporation Information Table 99. Dr. Reddy's Laboratories Corporation Information Table 100. Dr. Reddy's Laboratories Meloxicam Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 101. Dr. Reddy's Laboratories Main Product Table 102. Dr. Reddy's Laboratories Recent Development Table 103. Glenmark Pharmaceuticals Meloxicam Drug Corporation Information Table 104. Glenmark Pharmaceuticals Corporation Information Table 105. Glenmark Pharmaceuticals Meloxicam Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 106. Glenmark Pharmaceuticals Main Product Table 107. Glenmark Pharmaceuticals Recent Development Table 108. Teva Meloxicam Drug Corporation Information Table 109. Teva Corporation Information Table 110. Teva Meloxicam Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 111. Teva Main Product Table 112. Teva Recent Development Table 113. PuraCap Pharmaceutical Meloxicam Drug Corporation Information Table 114. PuraCap Pharmaceutical Corporation Information Table 115. PuraCap Pharmaceutical Meloxicam Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 116. PuraCap Pharmaceutical Main Product Table 117. PuraCap Pharmaceutical Recent Development Table 118. TARO Meloxicam Drug Corporation Information Table 119. TARO Corporation Information Table 120. TARO Meloxicam Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 121. TARO Main Product Table 122. TARO Recent Development Table 123. Lupin Pharmaceuticals Meloxicam Drug Corporation Information Table 124. Lupin Pharmaceuticals Corporation Information Table 125. Lupin Pharmaceuticals Meloxicam Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 126. Lupin Pharmaceuticals Main Product Table 127. Lupin Pharmaceuticals Recent Development Table 128. Aurobindo Pharma Meloxicam Drug Corporation Information Table 129. Aurobindo Pharma Corporation Information Table 130. Aurobindo Pharma Meloxicam Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 131. Aurobindo Pharma Main Product Table 132. Aurobindo Pharma Recent Development Table 133. Sales Base and Market Concentration Rate of Raw Material Table 134. Key Suppliers of Raw Materials Table 135. Meloxicam Drug Distributors List Table 136. Meloxicam Drug Customers List Table 137. Market Key Trends Table 138. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 139. Key Challenges Table 140. Global Meloxicam Drug Sales (K MT) Forecast by Type (2021-2026) Table 141. Global Meloxicam Drug Sales Market Share Forecast by Type (2021-2026) Table 142. Global Meloxicam Drug Revenue (Million US$) Forecast by Type (2021-2026) Table 143. Global Meloxicam Drug Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 144. Global Meloxicam Drug Sales (K MT) Forecast by Application (2021-2026) Table 145. Global Meloxicam Drug Revenue (Million US$) Forecast by Application (2021-2026) Table 146. Global Meloxicam Drug Sales (K MT) Forecast by Region (2021-2026) Table 147. Global Meloxicam Drug Sales Market Share Forecast by Region (2021-2026) Table 148. Global Meloxicam Drug Revenue Forecast by Region (2021-2026) (US$ Million) Table 149. Global Meloxicam Drug Revenue Market Share Forecast by Region (2021-2026) Table 150. Research Programs/Design for This Report Table 151. Key Data Information from Secondary Sources Table 152. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Meloxicam Drug Figure 2. Global Meloxicam Drug Sales Market Share by Type: 2020 VS 2026 Figure 3. Tablet Product Picture Figure 4. Capsule Product Picture Figure 5. Global Meloxicam Drug Consumption Market Share by Application: 2020 VS 2026 Figure 6. Osteoarthritis in adults (OA) Figure 7. Rheumatoid Arthritis in adults (RA) Figure 8. Pediatric patients Figure 9. Global Meloxicam Drug Market Size 2015-2026 (US$ Million) Figure 10. Global Meloxicam Drug Sales Capacity (K MT) (2015-2026) Figure 11. Global Meloxicam Drug Market Size Market Share by Region: 2020 Versus 2026 Figure 12. Meloxicam Drug Sales Share by Manufacturers in 2020 Figure 13. Global Meloxicam Drug Revenue Share by Manufacturers in 2019 Figure 14. The Global 5 and 10 Largest Players: Market Share by Meloxicam Drug Revenue in 2019 Figure 15. Meloxicam Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 16. Global Meloxicam Drug Sales Market Share by Region (2015-2020) Figure 17. Global Meloxicam Drug Sales Market Share by Region in 2019 Figure 18. Global Meloxicam Drug Revenue Market Share by Region (2015-2020) Figure 19. Global Meloxicam Drug Revenue Market Share by Region in 2019 Figure 20. North America Meloxicam Drug Sales Market Share by Country in 2019 Figure 21. North America Meloxicam Drug Revenue Market Share by Country in 2019 Figure 22. U.S. Meloxicam Drug Sales Growth Rate (2015-2020) (K MT) Figure 23. U.S. Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 24. Canada Meloxicam Drug Sales Growth Rate (2015-2020) (K MT) Figure 25. Canada Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 26. Europe Meloxicam Drug Sales Market Share by Country in 2019 Figure 27. Europe Meloxicam Drug Revenue Market Share by Country in 2019 Figure 28. Germany Meloxicam Drug Sales Growth Rate (2015-2020) (K MT) Figure 29. Germany Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 30. France Meloxicam Drug Sales Growth Rate (2015-2020) (K MT) Figure 31. France Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 32. U.K. Meloxicam Drug Sales Growth Rate (2015-2020) (K MT) Figure 33. U.K. Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 34. Italy Meloxicam Drug Sales Growth Rate (2015-2020) (K MT) Figure 35. Italy Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 36. Russia Meloxicam Drug Sales Growth Rate (2015-2020) (K MT) Figure 37. Russia Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 38. Asia Pacific Meloxicam Drug Sales Market Share by Region in 2019 Figure 39. Asia Pacific Meloxicam Drug Revenue Market Share by Region in 2019 Figure 40. China Meloxicam Drug Sales Growth Rate (2015-2020) (K MT) Figure 41. China Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 42. Japan Meloxicam Drug Sales Growth Rate (2015-2020) (K MT) Figure 43. Japan Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 44. South Korea Meloxicam Drug Sales Growth Rate (2015-2020) (K MT) Figure 45. South Korea Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. India Meloxicam Drug Sales Growth Rate (2015-2020) (K MT) Figure 47. India Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. Australia Meloxicam Drug Sales Growth Rate (2015-2020) (K MT) Figure 49. Australia Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. Taiwan Meloxicam Drug Sales Growth Rate (2015-2020) (K MT) Figure 51. Taiwan Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. Indonesia Meloxicam Drug Sales Growth Rate (2015-2020) (K MT) Figure 53. Indonesia Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. Thailand Meloxicam Drug Sales Growth Rate (2015-2020) (K MT) Figure 55. Thailand Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. Malaysia Meloxicam Drug Sales Growth Rate (2015-2020) (K MT) Figure 57. Malaysia Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. Philippines Meloxicam Drug Sales Growth Rate (2015-2020) (K MT) Figure 59. Philippines Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Vietnam Meloxicam Drug Sales Growth Rate (2015-2020) (K MT) Figure 61. Vietnam Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. Latin America Meloxicam Drug Sales Market Share by Country in 2019 Figure 63. Latin America Meloxicam Drug Revenue Market Share by Country in 2019 Figure 64. Mexico Meloxicam Drug Sales Growth Rate (2015-2020) (K MT) Figure 65. Mexico Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 66. Brazil Meloxicam Drug Sales Growth Rate (2015-2020) (K MT) Figure 67. Brazil Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. Argentina Meloxicam Drug Sales Growth Rate (2015-2020) (K MT) Figure 69. Argentina Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Middle East and Africa Meloxicam Drug Sales Market Share by Country in 2019 Figure 71. Middle East and Africa Meloxicam Drug Revenue Market Share by Country in 2019 Figure 72. Turkey Meloxicam Drug Sales Growth Rate (2015-2020) (K MT) Figure 73. Turkey Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 74. Saudi Arabia Meloxicam Drug Sales Growth Rate (2015-2020) (K MT) Figure 75. Saudi Arabia Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. U.A.E Meloxicam Drug Sales Growth Rate (2015-2020) (K MT) Figure 77. U.A.E Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. Sales Market Share of Meloxicam Drug by Type (2015-2020) Figure 79. Sales Market Share of Meloxicam Drug by Type in 2019 Figure 80. Revenue Share of Meloxicam Drug by Type (2015-2020) Figure 81. Revenue Market Share of Meloxicam Drug by Type in 2019 Figure 82. Global Meloxicam Drug Sales Growth by Type (2015-2020) (K MT) Figure 83. Global Meloxicam Drug Sales Market Share by Application (2015-2020) Figure 84. Global Meloxicam Drug Sales Market Share by Application in 2019 Figure 85. Global Revenue Share of Meloxicam Drug by Application (2015-2020) Figure 86. Global Revenue Share of Meloxicam Drug by Application in 2020 Figure 87. Boehringer-Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018 Figure 88. TerSera Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. Iroko Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Apotex Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Yung Shin Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Breckenridge Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Zydus Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Unichem Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Strides Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Cipla Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Dr. Reddy's Laboratories Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Glenmark Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. Teva Total Revenue (US$ Million): 2019 Compared with 2018 Figure 100. PuraCap Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 101. TARO Total Revenue (US$ Million): 2019 Compared with 2018 Figure 102. Lupin Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 103. Aurobindo Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 104. Price Trend of Key Raw Materials Figure 105. Manufacturing Cost Structure of Meloxicam Drug Figure 106. Manufacturing Process Analysis of Meloxicam Drug Figure 107. Meloxicam Drug Industrial Chain Analysis Figure 108. Channels of Distribution Figure 109. Distributors Profiles Figure 110. Porter's Five Forces Analysis Figure 111. North America Meloxicam Drug Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 112. North America Meloxicam Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 113. Europe Meloxicam Drug Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 114. Europe Meloxicam Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 115. Latin America Meloxicam Drug Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 116. Latin America Meloxicam Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 117. Middle East and Africa Meloxicam Drug Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 118. Middle East and Africa Meloxicam Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 119. Asia Pacific Meloxicam Drug Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 120. Asia Pacific Meloxicam Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 121. Bottom-up and Top-down Approaches for This Report Figure 122. Data Triangulation Figure 123. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

New Pharmaceuticals and Healthcare Reports

Other Reports by QY Research

Global Industrial Shock Absorber Market Research Report 2020

This report focuses on Industrial Shock Absorber volume and value at global level, regional level and company level. From a global perspective, this report represents overall Industrial Shock Absorber market size by analyzing historical data and futu...

Global Automotive Panoramic Sunroof Market Research Report 2020

This report focuses on Automotive Panoramic Sunroof volume and value at global level, regional level and company level. From a global perspective, this report represents overall Automotive Panoramic Sunroof market size by analyzing historical data an...

Global Flexible Fuel Tank Market Research Report 2020

This report focuses on Flexible Fuel Tank volume and value at global level, regional level and company level. From a global perspective, this report represents overall Flexible Fuel Tank market size by analyzing historical data and future prospect. R...

Global Rigid Drum Liner Market Research Report 2020

This report focuses on Rigid Drum Liner volume and value at global level, regional level and company level. From a global perspective, this report represents overall Rigid Drum Liner market size by analyzing historical data and future prospect. Regio...

Global Semi-rigid Drum Liner Market Research Report 2020

This report focuses on Semi-rigid Drum Liner volume and value at global level, regional level and company level. From a global perspective, this report represents overall Semi-rigid Drum Liner market size by analyzing historical data and future prosp...

Publisher: QY Research